Pharmaceutical Quality (Industry)
1.0.0 - STU1 International flag

This page is part of the Pharmaceutical Quality (Industry) (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example PlanDefinition: PlanDefinition - Drug - example, stability study protocol

Active as of 2024-05-08

Generated Narrative: PlanDefinition

Resource PlanDefinition "plandefinition-drug-pq-ex5-stability-study-protocol"

Profile: PlanDefinition - Drug PQ

url: http://example-server.com/fhir/PlanDefinition/plandefinition-drug-pq-ex5-stability-study-protocol

identifier: URI/urn:oid:2.16.840.1.113883.4.642.40.41.34.5

version: 1.0.0

title: Stability Monitoring Program

type: Stability Study Protocol (Pharmaceutical Plan Type Codes#1244588)

status: active

subject: MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1

date: 2024-05-08 13:23:45+0000

publisher: HL7 International / Biomedical Research and Regulation

contact: HL7 International - Biomedical Research and Regulation: http://www.hl7.org/Special/committees/rcrim

description: Narrative description of Stability Study

jurisdiction: World (m49.htm#001)

action

title: Stability Test Protocol for Long-term and Accelerated Storage of Stelbat Tablets, 20 mg

action

title: Long-Term

description: 25°C/60% RH

action